Medical Cannabis for Multiple Sclerosis in Costa Rica
What MS Does
Multiple sclerosis is a neurodegenerative disease of the nervous system. It is defined by inflammation, by the formation of plaques within the central nervous system, and by destruction of the myelin sheaths that insulate and protect nerves throughout the body. Once neurons are damaged this way they cannot repair themselves or transmit signals properly.
There is no cure, and MS is a lifelong condition that can progressively affect the brain, spinal cord, eyes and other systems. Clinicians recognise four forms: relapsing-remitting MS, by far the most common, secondary-progressive MS, primary-progressive MS, and the rare progressive-relapsing form.
Symptoms
Which symptoms appear, and how severely, depends on where in the nervous system the damage sits. They include numbness and tingling, known clinically as paraesthesia, along with pain, tremor, muscle weakness, spasticity and changes to functions such as walking, described as ataxia, or swallowing.
Early warning signs frequently include:
- Weakness
- Tingling or numbness
- Vertigo, with dizziness, loss of balance, nausea and ringing in the ears
- Pain in the chest, arms or legs
- Constipation
- Fatigue
- Insomnia
- Depression
- Difficulty concentrating
- Bladder infections
- Seizures
As the disease advances, patients commonly contend with pain, muscle spasm, numbness, poor balance and coordination, weakness, blurred vision, recurrent bladder infections, constipation, speech difficulty and memory loss.
What the Evidence Shows
The rationale for cannabis in MS rests on two properties working together: the anti-inflammatory action of cannabinoids and their pain relieving effect. Published literature recognises medical cannabis as effective in managing paraesthesia, acute and chronic pain, ataxia, spasticity and tremor.
Several randomised controlled trials have examined this directly, and participants have shown significant reductions in both spasticity and pain. In a 2013 randomised controlled trial, Corey-Bloom and colleagues found that inhaled cannabis reduced spasticity by roughly twenty-five per cent relative to placebo, with patients in the same study reporting close to a fifty per cent reduction in pain.
Work continues on optimal potency. Current findings suggest patients report better symptom control with preparations containing around twelve per cent THC than with lower concentrations, but this is exactly the kind of decision that belongs with a prescribing physician rather than a patient experimenting alone.
The comparatively mild side-effect profile, set against conventional MS medications, is a large part of why so many patients raise the subject with us.
Bladder Control
This surprises most patients. The body produces its own cannabinoids, and a substantial number of cannabinoid receptors sit in the walls of the bladder. Incontinence is a frequent and deeply frustrating feature of MS, whether from constant urgency during the day or from spinal nerve damage affecting bladder control. Cannabis oil can improve muscle and nerve function along the bladder wall. It also has a mild laxative effect, which helps with the constipation and associated discomfort that so often accompanies MS.
Treatment Approach
Carefully monitored cannabinoid protocols designed to support symptom management for neurological conditions.
⚠️ Medical cannabis treatment should always be supervised by a qualified physician. Results may vary by individual.
